Axunio Ltd
Axunio Ltd is a UK-based pharmaceutical company headquartered in Reading, England, and the UK subsidiary of Axunio Pharma GmbH (Germany). Formerly operating as Leith Healthcare Limited, the company rebranded as Axunio Ltd in July 2025 following its acquisition by Axunio Pharma GmbH. Specialising in innovative healthcare brands that address unmet patient needs, Axunio Ltd holds the UK Marketing Authorisation for Axhidrox (glycopyrronium bromide cream), a topical prescription treatment for severe primary axillary hyperhidrosis in adults, which received UK marketing authorisation in June 2025.
How to Contact Axunio Ltd
Phone
+44 (0)118 205 4880Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
